Cargando…
Erratum to: Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
Autores principales: | Matsumura, Mihoko, Nakatani, Yuki, Tanka, Seiichi, Aoki, Chie, Sagara, Masaaki, Yanagi, Kazunori, Suzuki, Kunihiro, Aso, Yoshimasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688979/ https://www.ncbi.nlm.nih.gov/pubmed/29063509 http://dx.doi.org/10.1007/s13300-017-0308-x |
Ejemplares similares
-
Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
por: Matsumura, Mihoko, et al.
Publicado: (2017) -
Clinical Implication of Plasma Hydrogen Sulfide Levels in Japanese Patients with Type 2 Diabetes
por: Suzuki, Kunihiro, et al.
Publicado: (2017) -
Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index
por: Aoki, Chie, et al.
Publicado: (2017) -
Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case–control study
por: Sagara, Masaaki, et al.
Publicado: (2016) -
Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon: Erratum
Publicado: (2015)